Table 1 Study methods
From: Performance-based financing for improving HIV/AIDS service delivery: a systematic review
Author (Year) | Study Setting | Study Design | Years | Follow-up | Intervention group | Comparator group | Outcomes | Analytic Model | Losses to follow-up |
|---|---|---|---|---|---|---|---|---|---|
Attiah (2010) [34] | 116 health facilities in Cote d'Ivoirea | Contemporaneous observational study | 2008-2009 | 18Â months | Facilities implementing PBF | Different facilities not implementing PBF | -% of women that received HTC -% of pregnant women that received ARV prophylaxis -% of infants that received ARV prophylaxis | Crude risk ratios | Not relevant (HIV testing and ARV prophylaxis reported) |
DeWalque (2015) [33] | 24 health facilities in Rwanda | Cluster randomised trial | 2006-2008 | 14-18 months | Facilities implementing PBF | Different facilities not implementing PBF | -% of all individuals receiving HIV testing -% of couples receiving HIV testing | Risk ratios adjusted for year, age, gender, years of schooling, and household wealth | Not relevant (HIV testing reported) |
Odeny (2013) [35] | 60 health facilities in Kenya | Contemporaneous observational study | 2007-2012 | 6-12 months | Facilities implementing PBF | Different facilities not implementing PBF | -Treatment failure (CD4 persistently below 100 cells/mm3 after 6–12 months of ART, CD4 falls by ≥50% from on treatment peak value, CD4 falls to or below pre-ART level) | Odds ratio adjusted baseline patient characteristics, year of ART initiation, and CD4 cell count at initiation | Not reported |
Tanoh (2009) [36] | 4 health facilities in Cote d'Ivoirea | Time-series observational study | 2005-2007 | 24Â months | Facilities implementing PBF | Same facilities before they implemented PBF | -ART coverage -Attrition after 12Â months | Crude risk ratios | Not reported |